Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma
机构:[1]Department of Radiology, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, People’s Republic of China[2]Department of Pathology, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, People’s Republic of China[3]Department of Radiology, Xuanwu Hospital Capital Medical University, Beijing, 100073, People’s Republic of China医技科室放射科首都医科大学宣武医院[4]Department of Nutrition, School of Public Health, Anhui Medical University, Hefei, Anhui, 230032, People’s Republic of China
Purpose: To explore the imaging performance for discrimination of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) and hepatocellular carcinoma (HCC).Methods: In total, 35 patients with cHCC-CCA and a matched control group of HCC patients (n = 35) were included retrospectively. We quantitatively evaluated the hypovascular component in tumor and qualitatively assessed LI-RADS features and other aggressive features to develop model for cHCC-CCA diagnose. Subgroup analyses were performed by tumor size and LI-RADS category.Results: cHCC-CCA frequently showed a larger proportion (>50%) of hypovascular areas followed by HCC (P = 0.000). Among those patients with >50% hypovascular areas, 8 patients did not present rim enhancement in atrial phase. The LI-RADS major features were more commonly observed in HCC (82.9-45.7%,), than cHCC-CCA (P = 0.003-0.022). The targetoid appearances and non -smooth margin frequently appeared in cHCC-CCA (34.3-63.9%), compared with HCC (P = 0.000-0.023). We developed a radiologic model based on >50% hypovascular component and delayed enhancement, which presented AUC of 0.821, accuracy of 80%. We also obtained good performance by radiologic model in LR-M group and tumor size <50mm group (AUC: 0.841 and 0.866, respectively). Combined group which included CA 19-9 and >50% hypovascular component and delayed enhancement did not improve the distinction performance between cHCC-CCA and HCC, which presented good performance of identifying cHCC-CCA in the LR-4/ 5 subgroup and tumor size >50 mm subgroup (AUC: 0.717, 0.730, respectively). cHCC-CCA group presented heterogeneous dominant pathology involving 15 of HCC, 7 of intrahepatic cholangiocarcinoma (iCCA) or cholangiolocellular carcinoma (CLC), 13 of intermediate cells component. Macrotrabecular appearances were higher in cHCC-CCA than that in HCC. The proportion of Hepa-1 was significantly higher in true negative (TN) patients (29 [93.5%]) and false negative (FN) patients (10 [100%]) than in true positive (TP) patients (16 [64%]; P = 0.036). Conclusion: Quantitative assessment of hypovascular component could help the discrimination of cHCC-CCA. Macrotrabecular appearances were more exhibited in cHCC-CCA than that in HCC.
基金:
National Natural Science Foundation of China [61936013]; Beijing Natural Science Foundation [7212051]; Beijing Excellent Talent Plan [2018000021469G290]
第一作者机构:[1]Department of Radiology, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Radiology, Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, People’s Republic of China[*1]Department of Radiology, Beijing YouAn Hospital, Capital Medical University, No. 8 Xi Tou Tiao, Youanmen Wai, Fengtai District, Beijing, 100069, People’s Republic of China
推荐引用方式(GB/T 7714):
Yang Xue,Chang Jing,Li Ruili,et al.Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma[J].JOURNAL OF HEPATOCELLULAR CARCINOMA.2023,10:113-122.doi:10.2147/JHC.S390820.
APA:
Yang, Xue,Chang, Jing,Li, Ruili,Qi, Yu,Zeng, Xufen...&Li, Hongjun.(2023).Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma.JOURNAL OF HEPATOCELLULAR CARCINOMA,10,
MLA:
Yang, Xue,et al."Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma".JOURNAL OF HEPATOCELLULAR CARCINOMA 10.(2023):113-122